Japan

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

Kyorin pens $105M pact for Japan rights to Hinge's lupus drug

Kyorin has strengthened its autoimmune portfolio by paying $10 million upfront for the Japan rights to Hinge Bio’s preclinical lupus drug.
James Waldron Oct 1, 2025 6:40am
A close-up view of a jigsaw puzzle with a missing piece

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am
GE Healthcare Building

Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan

Sep 24, 2025 11:30am
RNA Concept 3D Render

Japan biotech inks RNA research pact that includes mRNA compounds

Sep 19, 2025 10:49am
Three blocks displaying from left to right a person a handshake and another person

Kissei pays Viridian $70M to challenge Amgen for Japanese market

Jul 30, 2025 4:50am
gold bank vault door

AN Venture Partners raises $200M to boost Japan biotech industry

Jul 2, 2025 11:45am